Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Chromocell Therapeutics Corp | Director | Common Stock | 546K | $513K | $0.94 | Feb 21, 2024 | Direct |
Chromocell Therapeutics Corp | Director | Restricted Stock Units | 610K | Jun 14, 2024 | Direct | ||
Chromocell Therapeutics Corp | Director | Secured Convertible Promissory Note | 0 | Feb 21, 2024 | Balmoral Financial Group LLC |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CHRO | Chromocell Therapeutics Corp | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
CHRO | Chromocell Therapeutics Corp | Feb 21, 2024 | 1 | $100K | 4/A | Mar 12, 2024 | Director |
CHRO | Chromocell Therapeutics Corp | Feb 21, 2024 | 4 | $99.1K | 4 | Feb 23, 2024 | Director |
CHRO | Chromocell Therapeutics Corp | Feb 15, 2024 | 0 | $0 | 3 | Feb 15, 2024 | Director, 10%+ Owner |